课题基金 / 基金详情

项目摘要

项目成果

GARRET A FITZGERALD的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This highly integrated program is focused on the study of factors influencing discrete regional susceptibility to atherogenesis. The complex interplay of mechanical forces and chemical mediators which impinge on platelet vascular interactions and on cells of the vessel wall and their interaction with the extracellular matrix will be elucidated. Distinct and overlapping signaling pathways will be integrated by genomic and proteomic interrogation of determinants of the balance between susceptibility to and protection from atherosclerosis. Particular attention will be paid to how traditional risk factors, including age, hyperiipidemia and gender condition cell signaling pathways of relevance to inflammation and the cell cycle. In Project 1 the role of COX-2 and mPGES-1, will be assessed. Novel mouse models will delineate their contribution in endothelial, vascular smooth muscle cells, macrophages and cardiomyocytes to cardiovascular function. A priori hypothesis testing will complement unbiased approaches to assess the impact of enzyme disruption on discrete phenotypes and biological networks. In Project 4 the interaction between the ApoE/COX-2/PGl2/IP pathway and the cell cycle will be probed, using cell specific deletions and forced expression of COX-2, deletion, antagonism and stimulation of the IP and by using biophysical approaches to assess differential impact on the extracellular matrix. Finally, in Project 5 we shall examine the effect of gender and hyperiipidemia on the discrete expression of genomic subsets in endothelial cells obtained from regions of the pig aorta susceptible to and protected from atherogenesis. This program will take an integrated approach to the study of humoral and mechanical signaling in vascular cells. Factors that underlie the cell to cell heterogeneity of this interaction are likely to contribute to the focal nature of atherogenesis.
期刊论文(94)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/clpt.2012.3
发表时间: 2012-06
期刊: Clinical pharmacology and therapeutics
影响因子: 6.7
作者: []
通讯作者:
DOI: 10.1126/scisignal.2004838
发表时间: 2014-06-17
期刊: Science signaling
影响因子: 7.3
作者: [Bae YH, Mui KL, Hsu BY, Liu SL, Cretu A, Razinia Z, Xu T, Puré E, Assoian RK]
通讯作者: Assoian RK
Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma.
15-脱氧-delta12,14-PGJ2 的生物合成和 PPARgamma 的连接。
DOI: 10.1172/jci18012
发表时间: 2003
期刊: The Journal of clinical investigation.
影响因子: --
作者: [Bell-Parikh,LChastine, Ide,Tomomi, Lawson,JohnA, McNamara,Peter, Reilly,Muredach, FitzGerald,GarretA]
通讯作者: FitzGerald,GarretA
A new approach to the synthesis of polyunsaturated deuterated isoprostanes: total synthesis of d4-5-epi-8,12-iso-iPF3alpha-VI and d4-8,12-iso-iPF3alpha-VI.
多不饱和氘代异前列烷合成新方法:d4-5-epi-8,12-iso-iPF3alpha-VI和d4-8,12-iso-iPF3alpha-VI的全合成。
DOI: 10.1016/j.bmcl.2009.09.099
发表时间: 2009
期刊: Bioorganic & medicinal chemistry letters
影响因子: 2.7
作者: [Chang,Chih-Tsung, Patel,Pranav, Gore,Vivek, Song,Wen-Liang, Lawson,JohnA, Powell,WilliamS, Fitzgerald,GarretA, Rokach,Joshua]
通讯作者: Rokach,Joshua
46
    Institutional Clinical and Translational Sciences Award
    • 批准号:
      10487653
    • 项目类别:
    • 资助金额:
      $6.13万
    • 财政年份:
      2022
    • 负责人:
      GARRET A FITZGERALD
    • 依托单位:
    Atherosclerosis, Prostaglandin Inhibition and Checkpoint Blockade
    • 批准号:
      10304145
    • 项目类别:
    • 资助金额:
      $65.41万
    • 财政年份:
      2019
    • 负责人:
      GARRET A FITZGERALD
    • 依托单位:
    Atherosclerosis, Prostaglandin Inhibition and Checkpoint Blockade
    • 批准号:
      10065018
    • 项目类别:
    • 资助金额:
      $66.99万
    • 财政年份:
      2019
    • 负责人:
      GARRET A FITZGERALD
    • 依托单位:
    Institutional Clinical and Translational Science Award
    • 批准号:
      10348879
    • 项目类别:
    • 资助金额:
      $1016.45万
    • 财政年份:
      2016
    • 负责人:
      GARRET A FITZGERALD
    • 依托单位:
    国内基金
    海外基金
    补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
    靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
    • 批准号:
      JCZRQN202500010
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
    • 依托单位:
    对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
    • 批准号:
      2025JJ70209
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      雷芬芳
    • 依托单位:
    AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      万荣
    • 依托单位: